Device profile of the Zephyr endobronchial valve in heterogenous emphysema: overview of its safety and efficacy

References

• National Heart, Lung, and Blood Institute. COPD national action plan. 2021. 2021 Mar 28
   Google Scholar
• Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax. 2008;63(9):761–767.
   PubMed Web of Science ®Google Scholar
• Zantah M, Gangemi AJ, Criner GJ. Bronchoscopic lung volume reduction: status quo. Ann Transl Med. 2020;8(21):1469.
   PubMed Web of Science ®Google Scholar
• Rossi A, Aisanov Z, Avdeev S, et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med. 2015;109(7):785–802.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23(6):832–840.
   PubMed Web of Science ®Google Scholar
• Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–2073.
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164.
   Web of Science ®Google Scholar
• Hopkinson NS, Molyneux A, Pink J, et al. (GC) GC. Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance. BMJ. 2019;366:l4486.
   PubMedGoogle Scholar
• Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13):1233–1244.
   PubMed Web of Science ®Google Scholar
• Herth FJ, Eberhardt R, Gompelmann D, et al. Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. Eur Respir J. 2013;41(2):302–308.
   PubMed Web of Science ®Google Scholar
• Klooster K, ten Hacken NH, Hartman JE, et al. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373(24):2325–2335.
   PubMed Web of Science ®Google Scholar
• Davey C, Zoumot Z, Jordan S, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015;386(9998):1066–1073.
   PubMed Web of Science ®Google Scholar
• Kemp SV, Slebos DJ, Kirk A, et al. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;196(12):1535–1543.
   PubMed Web of Science ®Google Scholar
• Valipour A, Slebos DJ, Herth F, et al. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study. Am J Respir Crit Care Med. 2016;194(9):1073–1082.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Sue R, Wright S, et al. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med. 2018;198(9):1151–1164.
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Garner JL, Bhatt SP, et al. Effect of Zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year. Results from a randomized clinical trial. Ann Am Thorac Soc. 2020;17(7):829–838.
   PubMed Web of Science ®Google Scholar
• Pulmonx endobronchial valves used in treatment of emphysema (LIBERATE Study). [cited 2021 Apr 4]. Available from: https://ClinicalTrials.gov/show/NCT01796392.
   Google Scholar
• Darwiche K, Karpf-Wissel R, Eisenmann S, et al. Bronchoscopic lung volume reduction with endobronchial valves in low-FEV1 patients. Respiration. 2016;92(6):414–419.
   PubMed Web of Science ®Google Scholar
• van Dijk M, Hartman JE, Klooster K, et al. Endobronchial valve treatment in emphysema patients with a very low DLCO. Respiration. 2020;99(2):163–170.
   PubMed Web of Science ®Google Scholar
• Pulmonx: Patient Selection Guidance. 2020. [cited 2021 Mar 31]. Available from: https://physicians.mylungsmylife.com/patient-selection
   Google Scholar
• Criner GJ, Delage A, Voelker K, et al. Improving lung function in severe heterogenous emphysema with the spiration valve system (EMPROVE). A multicenter, open-label randomized controlled clinical trial. Am J Respir Crit Care Med. 2019;200(11):1354–1362.
   PubMed Web of Science ®Google Scholar
• Diso D, Anile M, Carillo C, et al. Correlation between collateral ventilation and interlobar lung fissures. Respiration. 2014;88(4):315–319.
   PubMed Web of Science ®Google Scholar
• Li S, Wang G, Wang C, et al. The REACH trial: a Randomized controlled trial assessing the safety and effectiveness of the spiration® valve system in the treatment of severe emphysema. Respiration. 2019;97(5):416–427.
   PubMed Web of Science ®Google Scholar
• Argula RG, Strange C, Ramakrishnan V, et al. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest. 2013;144(5):1578–1586.
   PubMed Web of Science ®Google Scholar
• Corporation P, Inventor. Zephyr endobronchial valve system protocol.
   Google Scholar
• Klooster K, van Dijk M, Koster TD, et al. First in human experience of the performance of the new 5.5-LP size Zephyr endobronchial valve. Respiration. 2020;99(1):50–55.
   PubMed Web of Science ®Google Scholar
• Slebos DJ, Shah PL, Herth FJ, et al. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from expert panel on endoscopic lung volume reduction. Respiration. 2017;93(2):138–150.
   PubMed Web of Science ®Google Scholar
• Corporation P, Inventor. Zephyr® endobronchial valve system. Accessed 2021 Apr 4th.
   Google Scholar
• Fiorelli A, Poggi C, Anile M, et al. Visual analysis versus quantitative CT analysis of interlobar fissure integrity in selecting emphysematous patients for endobronchial valve treatment. Interact Cardiovasc Thorac Surg. 2019;28(5):751–759.
   PubMed Web of Science ®Google Scholar
• Gesierich W, Samitas K, Reichenberger F, et al. Collapse phenomenon during Chartis collateral ventilation assessment. Eur Respir J. 2016;47(6):1657–1667.
   PubMed Web of Science ®Google Scholar
• Fiorelli A, Santini M, Shah P. When can computed tomography-fissure analysis replace Chartis collateral ventilation assessment in the prediction of patients with emphysema who might benefit from endobronchial valve therapy? Interact Cardiovasc Thorac Surg. 2018;26(2):313–318.
   PubMed Web of Science ®Google Scholar
• Corporation P. PulmonX: the Chartis tablet. 2021 Apr 4th.
   Google Scholar
• PulmonX Stratx. cited 2021 Apr 5.
   Google Scholar
• Klooster K, Slebos DJ. Endobronchial valves for the treatment of advanced emphysema. Chest. 2021;159(5):1833–1842.
   PubMed Web of Science ®Google Scholar
• Come CE, Kramer MR, Dransfield MT, et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015;46(3):651–662.
   PubMed Web of Science ®Google Scholar
• Valipour A, Slebos DJ, de Oliveira HG, et al. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema–potential mechanisms, treatment algorithm, and case examples. Respiration. 2014;87(6):513–521.
   PubMed Web of Science ®Google Scholar
• Fiorelli A, D’Andrilli A, Bezzi M, et al. Complications related to endoscopic lung volume reduction for emphysema with endobronchial valves: results of a multicenter study. J Thorac Dis. 2018;10(Suppl 27):S3315–S3325.
   PubMed Web of Science ®Google Scholar
• Shah PL, Zoumot Z, Singh S, et al. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med. 2013;1(3):233–240.
   PubMed Web of Science ®Google Scholar
• Deslée G, Mal H, Dutau H, et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA. 2016;315(2):175–184.
   PubMed Web of Science ®Google Scholar
• Sciurba FC, Criner GJ, Strange C, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA. 2016;315(20):2178–2189.
   PubMed Web of Science ®Google Scholar
• Herth FJF, Slebos DJ, Shah PL, et al. Protocol of a randomized controlled study of the pneumRx endobronchial coil system versus standard-of-care medical management in the treatment of subjects with severe emphysema (ELEVATE). Respiration. 2019;98(6):512–520.
   PubMed Web of Science ®Google Scholar
• Kontogianni K, Gerovasili V, Gompelmann D, et al. Coil therapy for patients with severe emphysema and bilateral incomplete fissures - effectiveness and complications after 1-year follow-up: a single-center experience. Int J Chron Obstruct Pulmon Dis. 2017;12:383–394.
   PubMed Web of Science ®Google Scholar
• Hartman JE, Klooster K, Gortzak K, et al. Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology. 2015;20(2):319–326.
   PubMed Web of Science ®Google Scholar
• Herth FJ, Eberhardt R, Ingenito EP, et al. Assessment of a novel lung sealant for performing endoscopic volume reduction therapy in patients with advanced emphysema. Expert Rev Med Devices. 2011;8(3):307–312.
   PubMed Web of Science ®Google Scholar
• Snell G, Herth FJ, Hopkins P, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J. 2012;39(6):1326–1333.
   PubMed Web of Science ®Google Scholar
• Herth FJ, Valipour A, Shah PL, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med. 2016;4(3):185–193.
   PubMed Web of Science ®Google Scholar
• Shah PL, Slebos DJ, Cardoso PF, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet. 2011;378(9795):997–1005.
   PubMed Web of Science ®Google Scholar